Kure Diagnostic & Clinic Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 80.00 K
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth %
- Ebitda
- Net Worth
- Total Assets 0.27%
About Kure Diagnostic & Clinic
Kure Diagnostic & Clinic Private Limited (KDCPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 July 2017 (Seven years and six months 8 days old ). Its registered office is in Kamrup, Assam, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 80.00 K , as per Ministry of Corporate Affairs (MCA) records.
Ansh Agarwalla, Elizabeth Engheepi, Gada Medhi, and One other member serve as directors at the Company.
Company Details
- Location
Kamrup, Assam, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U85100AS2017PTC018065
- Company No.
018065
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Jul 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Who are the key members and board of directors at Kure Diagnostic & Clinic?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gada Medhi  | Director | 24-Jul-2017 | Current |
| Ansh Agarwalla | Director | 24-Jul-2017 | Current |
| Elizabeth Engheepi | Director | 24-Jul-2017 | Current |
| Sanjay Medhi | Director | 24-Jul-2017 | Current |
Financial Performance of Kure Diagnostic & Clinic.
Kure Diagnostic & Clinic Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kure Diagnostic & Clinic?
Unlock access to Kure Diagnostic & Clinic's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Prithvi Pavers LlpAnsh Agarwalla is a mutual person
- Primax Tea Private Limited
Ansh Agarwalla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kure Diagnostic & Clinic?
Unlock and access historical data on people associated with Kure Diagnostic & Clinic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kure Diagnostic & Clinic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kure Diagnostic & Clinic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.